United States

Sumitomo Dainippon Pharma Co Ltd (4506.T)

4506.T on Tokyo Stock Exchange

21 Oct 2016
Change (% chg)

¥-12 (-0.64%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Dainippon Sumitomo Pharma Co Ltd and Takeda Pharmaceutical Company Ltd announce decision to terminate agreement
Thursday, 7 May 2015 02:00am EDT 

Dainippon Sumitomo Pharma Co Ltd and Takeda Pharmaceutical Company Ltd:Says their license agreement entered into in March 2011 (agreement) will be terminated.Says companies are starting discussions in an effort to finalize and execute a mutual agreement establishing a transition plan for orderly transfer of all development and commercialization rights and activities with respect to Latuda to Sumitomo Dainippon Pharma.Says agreement entered For joint development and exclusive commercialization of pharmaceutical products containing lurasidone hydrochloride (Latuda), an atypical antipsychotic agent, in Europe.Takeda's right to develop and commercialize Latuda within 26 member states of the European Union (excluding U.K), Switzerland, Norway, Turkey and Russia, will transfer back to Sumitomo Dainippon Pharma upon effective date of termination.  Full Article

BRIEF-Sumitomo Dainippon Pharma announces result of early-retirement program

* Says 295 employees took up the offer of the early-retirement program announced on Aug. 30